Flash Therapeutics
French tech company | Builders Republic
About
CDMO specialized in lentiviral vector production for pharma and biotech clients developing gene and cell therapies — from process development and upstream/downstream manufacturing to quality control and regulatory-ready batches, GMP-compliant.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Venture Round
- Founded
- 2005
- City
- TOULOUSE
- Region
- Occitanie
- Tracked rounds
- 1
- Amount raised
- 15 M€ raised since 2020
Funding rounds
- Venture Round · 2021
Investors
- Angel Investors Consortium
- Auriga Cyber Ventures
- Elaia Partners
- FaDièse
- FJ Investissements
- Galia Gestion
- Horizon 2020
- JMCR Family Office
- Nubbo
- Techlife Capital
- Viva Biotech
Notes
CDMO de vecteurs lentiviraux (Toulouse), rebaptisée Flash BioSolutions, placée en redressement judiciaire en novembre 2024 puis en liquidation judiciaire fin janvier 2025 (tribunal de commerce de Toulouse). Jugements au BODACC : procédure collective ouverte le 28/11/2024 ; liquidation judiciaire le 30/01/2025.